Jonathan Douxfils

86PUBLICATIONS

104CO-AUTHORS

Consumer-oriented product or service developmentRespiratory diseasesObstetrics and gynaecologyMedical biochemistry - nucleic acidsElectroanalytical chemistry

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (86)

Sort by Publication Date:

|May 15, 2026

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications.

|Apr 16, 2026

Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies.

|Feb 02, 2026

Venous Thromboembolism Risk Associated With Relugolix-estradiol-norethisterone Acetate Combination Therapy.

Jonathan Douxfils, Marie Didembourg, Lorraine Maitrot-Mantelet

|Jan 12, 2026

Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis.

Emma Calluy, Yveline Malrechauffé, Emma Boretti

|Nov 27, 2025

Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.

Job Harenberg, Robert C Gosselin, Adam Cuker

|Sep 27, 2025

Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61.

Jonathan Douxfils, Jean-Michel Foidart

Pageof 15

Frequent Collaborators

19 joint publications

François Mullier

13 joint publications

Constant Gillot

11 joint publications

Laure Morimont

Michael Hardy

Romain Siriez

Robert Gosselin

Marie Didembourg

Jonathan Evrard

Jean-Michel Foidart

Julien Favresse